Key highlights
- "Peptide therapy" covers very different drugs. Some are FDA-approved medicines with large trials, and some have only animal studies.
- GLP-1 peptides have the strongest evidence. Semaglutide averaged 14.9% weight loss, and tirzepatide up to 20.9% in large randomized trials.
- BPC-157 and TB-500 are still unproven in people. An FDA advisory panel voted 8 to 6 in July 2026 to allow compounding, against the advice of FDA's own scientists, and FDA hasn't acted on that vote yet.
- Worth the money depends on what you're buying. A peptide with trial evidence for your goal can justify the cost, and one without it is a gamble at $150 to $400 a month.
- "Research use only" peptides sold online are the riskiest option. FDA sent warning letters to four sellers in August 2026.
| Peptide therapy works for peptides with human trial evidence, like the GLP-1 medications semaglutide and tirzepatide, which produced 15% to 21% average weight loss in large trials. Wellness peptides like BPC-157 and TB-500 have mostly animal research, and FDA reviewers found their human studies too small to show they work. |
|---|
Table of contents
- Does peptide therapy actually work?
- The peptide evidence ladder
- Peptides that work: FDA-approved options
- Peptides with limited human evidence
- Where FDA rules stand in October 2026
- Are peptide injections worth the money?
- Five questions to ask before you pay
- What is the downside of peptide therapy?
- Who peptide therapy is right for
- Common myths about peptide therapy
- What-if scenarios
- Frequently asked questions
Does peptide therapy actually work?
Peptide therapy works for some peptides and some goals, and the answer depends entirely on which peptide you mean.
Peptides are short chains of amino acids that act as signals in the body. Insulin is a peptide, and so are semaglutide (the active ingredient in Wegovy and Ozempic) and BPC-157, which shows up in gym forums and wellness ads.
Those three sit at completely different levels of proof.
Insulin has been used for about a century, semaglutide has randomized trials with thousands of people, and BPC-157 rests mostly on rat studies and a handful of small human studies.
So when patients ask me whether peptide therapy works, I ask which peptide and for what. That question does more to protect your money than anything else in this article.
The peptide evidence ladder
The peptide evidence ladder ranks peptides by how much human proof they have, from FDA-approved medicines at the top to online "research" products at the bottom.
| Rung | Examples | Human evidence | Status in October 2026 | Typical monthly cost |
|---|---|---|---|---|
| 1. FDA-approved for weight and metabolism | Semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro) | Large randomized trials with thousands of people | Approved for specific conditions | $149 to $1,300+ |
| 2. FDA-approved for narrow uses | Tesamorelin (Egrifta), bremelanotide (Vyleesi) | Randomized trials for one specific condition | Approved for that condition only | Varies widely |
| 3. Recommended by an FDA panel, not yet acted on | BPC-157, TB-500, MOTS-c, KPV, Semax, Epitalon | A few small, short studies | Not approved, compounding status pending | $150 to $400 |
| 4. Sold online as "research use only" | Any peptide sold without a prescription | None for the product you receive | Can't legally be sold for human use | Cheap, with unknown contents |
Here's what most people miss. A clinic can call all four rungs "peptide therapy," and the price on rungs one and three can overlap. The difference is in what you're paying for, which is either a measured result or a hope.
Monthly costs reflect typical peptide therapy prices and the manufacturer's self-pay prices for Wegovy.
Peptides that work: FDA-approved options
The peptides with the strongest evidence are the GLP-1 medications, which produced 15% to 21% average weight loss in large trials.
In the STEP 1 trial, 1,961 adults on semaglutide 2.4 mg lost 14.9% of their body weight on average over 68 weeks, compared with 2.4% on placebo. Half of the semaglutide group lost 15% or more.
Tirzepatide went further. In the SURMOUNT-1 trial of 2,539 adults, average weight loss at 72 weeks was 15.0% on 5 mg, 19.5% on 10 mg, and 20.9% on 15 mg, compared with 3.1% on placebo.
These are the results I'd point to if someone asked me to prove a peptide works. It's also why GLP-1 injections are the core of our peptide care in Salem. Semaglutide mimics a gut hormone that slows digestion and reduces appetite, which is how semaglutide works for weight loss.
A few other peptides are FDA-approved for narrow uses. Tesamorelin treats excess belly fat in people with HIV-related lipodystrophy. Bremelanotide treats low sexual desire in premenopausal women. Neither is approved for general anti-aging or recovery.
Peptides with limited human evidence
BPC-157, TB-500, and similar wellness peptides have promising animal research and very little human data.
BPC-157 is the best-known example. Rat studies suggest it may help tendons, muscles, and the gut heal. In people, the record is thin. During the July 2026 review, the available human studies, including five trials of BPC-157, were described as short, small, and insufficient to establish safety or effectiveness.
TB-500, MOTS-c, Semax, and Epitalon sit in the same place. They're interesting compounds with early research, and none has the kind of human trial that would tell you how likely it is to help you.
Nobody knows yet whether they help people, and you'd be paying to find out. Our clinic doesn't currently offer BPC-157 for that reason.
Where FDA rules stand in October 2026
As of October 2026, BPC-157 and five other peptides have been recommended for compounding by an FDA advisory panel, and FDA hasn't made a final decision.
The rules have shifted three times in three years:
- September 2023: FDA placed BPC-157 and other peptides in Category 2, its list of substances with significant safety risks that pharmacies shouldn't compound.
- April 2026: FDA removed 12 peptides from Category 2, including BPC-157 and TB-500. That didn't approve them or clear them for compounding.
- July 23 and 24, 2026: FDA's Pharmacy Compounding Advisory Committee voted to recommend six peptides for the compounding list. BPC-157, KPV, and TB-500 passed 8 to 6.
Now this is where it gets interesting. In its briefing documents for that meeting, FDA proposed that each peptide not be added to the list. The panel voted yes anyway, by narrow margins. Its votes are recommendations, and FDA still has to decide whether to accept them and go through rulemaking.
So the experts split almost down the middle. That alone tells you how uncertain the evidence is.
Are peptide injections worth the money?
Peptide injections are worth the money when there's human evidence they work for your goal, a licensed provider is monitoring you, and you can afford to stay on them long enough to see results.
Let's do the math together. At the manufacturer's self-pay price of $349 a month, a year of Wegovy injections costs about $4,188. In return, the average person in the main trial lost about 15% of their body weight. That's a measurable result for a known price.
A wellness peptide at $150 to $400 a month costs $1,800 to $4,800 a year. Without a human trial, nobody can tell you what the average result looks like, or whether there is one.
There's another cost people forget. Results from GLP-1s depend on staying on them. In the STEP 1 trial extension, people who stopped semaglutide regained about two-thirds of the weight they'd lost within a year. So budget for the long term, and talk with your provider about a plan for maintenance.
Five questions to ask before you pay
Ask these five questions about any peptide, and you'll know whether it's a good use of your money.
- Is it FDA-approved for my goal? If yes, ask for the trial results. If no, ask why the provider recommends it anyway.
- What did human studies show? "It helps rats heal" doesn't tell you what it'll do for your knee.
- Where does it come from? Prescription medications come from licensed pharmacies. "Research use only" vials don't.
- How will we know it's working? A good plan has a measurable goal, like weight, lab values, or a symptom score, and a date to check it.
- What's the full yearly cost? Include labs, visits, and how long you'd need to stay on it.
If a provider can't answer the first two clearly, the peptide is an experiment. You're allowed to say no to experiments.
What is the downside of peptide therapy?
The downsides of peptide therapy are side effects, unknown long-term safety for unapproved peptides, contamination risk from unregulated sources, and cost.
- Side effects of approved peptides. GLP-1s commonly cause nausea, constipation, and other stomach symptoms, especially early on, and most Ozempic side effects ease as your body adjusts.
- Unknown long-term safety. Unapproved peptides haven't been studied long enough to know what years of use do.
- Contamination. Products sold online can contain the wrong dose, the wrong substance, or impurities.
- Immune reactions. FDA's original concerns about several peptides included immune responses to the injected product.
- Cost without a clear result. Paying monthly for something with no measurable goal adds up fast.
Red flags:
- A seller who ships injectable peptides without a prescription or a medical visit. Buying weight loss drugs from online stores carries the same risk.
- "For research use only" or "not for human consumption" on a product meant for injection.
- A provider who promises healing, anti-aging, or muscle gain from an unapproved peptide.
- No labs, no follow-up, and no plan to measure whether it's working.
In August 2026, the FDA sent warning letters to four online peptide sellers and rejected their "research use only" disclaimers, since the sellers were clearly marketing the products for injection.
Who peptide therapy is right for
Peptide therapy is best suited to adults with a specific medical goal that an approved peptide treats, such as weight loss with obesity or overweight and a related health condition.
Peptide therapy may be a good fit if you:
- Have a BMI and health profile that meets the criteria for a GLP-1 medication.
- Want medical supervision with labs and regular check-ins from a licensed provider you've vetted.
- Are willing to pair medication with changes to eating and activity.
It's probably a poor fit if you:
- Want a general "anti-aging" boost with no specific goal.
- Are pregnant, planning a pregnancy, or breastfeeding.
- Are hoping a peptide will replace sleep, training, and nutrition.
The peptide therapy program in Salem starts with a free consultation, where I look at your goals and health history before recommending anything.
Common myths about peptide therapy
- "Peptides are natural, so they're safe." Your body makes peptides, but a manufactured injection at a therapeutic dose is a drug, with drug risks.
- "The FDA approved BPC-157 in 2026." It didn't. FDA removed it from a restricted list, and an advisory panel recommended compounding, but neither step is an approval.
- "Online peptides are the same as clinic peptides." Online "research" peptides aren't made or tested for human use, and you can't confirm what's in the vial.
- "If it works for athletes, it'll work for me." Anecdotes aren't evidence, and BPC-157 is banned by the World Anti-Doping Agency.
What-if scenarios
What if you're already using a peptide you bought online? Stop and talk to a provider. Bring the vial and any paperwork so they can see what you've been taking.
What if a GLP-1 isn't working for you? Dose, timing, and eating patterns are common reasons people aren't losing weight on semaglutide, and your provider can adjust the plan.
What if you want peptides for recovery from an injury? Start with a diagnosis. Physical therapy and proven treatments have far more evidence than any recovery peptide.
What if you're choosing between Wegovy and Ozempic? They contain the same active ingredient, and the differences between Wegovy and Ozempic come down to dose and approved use.
Not sure whether this fits your recovery?
A straight conversation beats a checkout cart. Bring your questions to a licensed provider who knows the current evidence and the current law.
Frequently asked questions
Does peptide therapy actually work?
Peptide therapy works for peptides with human trial evidence, like the GLP-1 medications semaglutide and tirzepatide, which produced 15% to 21% average weight loss in large trials. Wellness peptides like BPC-157 and TB-500 have mostly animal research, and FDA reviewers found their human studies too small to show they work.
Are peptide injections worth the money?
Peptide injections are worth the money when there's human evidence they work for your goal and a licensed provider monitors you. A year of Wegovy at the $349 self-pay price costs about $4,188 for a trial-proven result. Unapproved wellness peptides at $150 to $400 a month have no comparable proof.
What is the downside of peptide therapy?
The downsides of peptide therapy include side effects like nausea with GLP-1s, unknown long-term safety for unapproved peptides, contamination in products sold online, and ongoing cost. GLP-1 results also depend on staying on the medication, since people in one trial regained two-thirds of their lost weight within a year of stopping.
What is the most risky peptide?
The riskiest peptide is any one sold online as "research use only," because you can't confirm what's in the vial or how it was made. Among specific compounds, unapproved peptides with little human data, like BPC-157 and TB-500, carry more unknowns than FDA-approved peptides with large safety trials.
Is BPC-157 legal in 2026?
BPC-157 isn't FDA-approved for any use. In April 2026, FDA removed it from its list of peptides with significant safety risks, and in July 2026 an advisory panel recommended allowing compounding by an 8 to 6 vote. As of October 2026, FDA hasn't finalized that recommendation.

